Imagine designing a medication trial hoping to demonstrate one benefit…and then finding out that your study drug just happens to have significant additional health benefits? You’d be jumping for joy! Well, that’s exactly what happened with the GLP-1 receptor agonists. Originally intended for treatment of type 2 diabetes, they’re now making huge waves in the fight against obesity. Learn how in this star-studded post!
Read More